Literature DB >> 9950271

Artificial neural network as a novel method to optimize pharmaceutical formulations.

K Takayama1, M Fujikawa, T Nagai.   

Abstract

One of the difficulties in the quantitative approach to designing pharmaceutical formulations is the difficulty in understanding the relationship between causal factors and individual pharmaceutical responses. Another difficulty is desirable formulation for one property is not always desirable for the other characteristics. This is called a multi-objective simultaneous optimization problem. A response surface method (RSM) has proven to be a useful approach for selecting pharmaceutical formulations. However, prediction of pharmaceutical responses based on the second-order polynomial equation commonly used in RSM, is often limited to low levels, resulting in poor estimations of optimal formulations. The aim of this review is to describe the basic concept of the multi-objective simultaneous optimization technique in which an artificial neural network (ANN) is incorporated. ANNs are being increasingly used in pharmaceutical research to predict the non-linear relationship between causal factors and response variables. The usefulness and reliability of this ANN approach is demonstrated by the optimization for ketoprofen hydrogel ointment as a typical numerical example, in comparison with the results obtained with a classical RSM approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950271     DOI: 10.1023/a:1011986823850

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Formula optimization based on artificial neural networks in transdermal drug delivery.

Authors:  K Takayama; J Takahara; M Fujikawa; H Ichikawa; T Nagai
Journal:  J Control Release       Date:  1999-11-01       Impact factor: 9.776

2.  Formulation optimization of sustained-release tablet of chlorpheniramine maleate by means of extreme vertices design and simultaneous optimization technique.

Authors:  M Hirata; K Takayama; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-03       Impact factor: 1.645

3.  Application of neural computing in pharmaceutical product development.

Authors:  A S Hussain; X Q Yu; R D Johnson
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

4.  Computer optimization of pharmaceutical formulations. I. General procedure.

Authors:  J B Schwartz; J R Flamholz; R H Press
Journal:  J Pharm Sci       Date:  1973-07       Impact factor: 3.534

5.  Mathematical optimization techniques in drug product design and process analysis.

Authors:  D E Fonner; J R Buck; G S Banker
Journal:  J Pharm Sci       Date:  1970-11       Impact factor: 3.534

6.  Optimized synthesis of polyglutaraldehyde nanoparticles using central composite design.

Authors:  A D McLeod; F C Lam; P K Gupta; C T Hung
Journal:  J Pharm Sci       Date:  1988-08       Impact factor: 3.534

7.  Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks.

Authors:  J V Gobburu; W H Shelver
Journal:  J Pharm Sci       Date:  1995-07       Impact factor: 3.534

8.  Mathematical optimization of formulation of indomethacin/polyvinylpolypyrrolidone/methyl cellulose solid dispersions by the sequential unconstrained minimization technique.

Authors:  K Takayama; H Imaizumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-01       Impact factor: 1.645

9.  Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin.

Authors:  K Takayama; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-01       Impact factor: 1.645

10.  Neural computing in cancer drug development: predicting mechanism of action.

Authors:  J N Weinstein; K W Kohn; M R Grever; V N Viswanadhan; L V Rubinstein; A P Monks; D A Scudiero; L Welch; A D Koutsoukos; A J Chiausa
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  13 in total

1.  Towards more optimal medical diagnosing with evolutionary algorithms.

Authors:  V Podgorelec; P Kokol
Journal:  J Med Syst       Date:  2001-06       Impact factor: 4.460

2.  Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance.

Authors:  Svetlana Ibrić; Milica Jovanović; Zorica Djurić; Jelena Parojcić; Slobodan D Petrović; Ljiljana Solomun; Biljana Stupar
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

3.  Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development.

Authors:  Wendy I Wilson; Yun Peng; Larry L Augsburger
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

4.  A novel preformulation tool to group microcrystalline celluloses using artificial neural network and data clustering.

Authors:  Josephine L P Soh; Fei Chen; Celine V Liew; Daming Shi; Paul W S Heng
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 5.  Application of micro- and nano-electromechanical devices to drug delivery.

Authors:  Mark Staples; Karen Daniel; Michael J Cima; Robert Langer
Journal:  Pharm Res       Date:  2006-05-05       Impact factor: 4.200

6.  Artificial neural network for modeling formulation and drug permeation of topical patches containing diclofenac sodium.

Authors:  Sonia Lefnaoui; Samia Rebouh; Mounir Bouhedda; M Madiha Yahoum
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

7.  Adaptive neuro-fuzzy modeling of poorly soluble drug formulations.

Authors:  Dionysios Douroumis; Leontios J Hadjileontiadis; Alfred Fahr
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

8.  Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Authors:  Tianyuan Fan; Kozo Takayama; Yoshiyuki Hattori; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

9.  Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes.

Authors:  Narayanaswamy Subramanian; Archit Yajnik; Rayasa S Ramachandra Murthy
Journal:  AAPS PharmSciTech       Date:  2004-02-02       Impact factor: 3.246

10.  Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks.

Authors:  Hanne Kinnunen; Gerald Hebbink; Harry Peters; Jagdeep Shur; Robert Price
Journal:  AAPS PharmSciTech       Date:  2014-05-16       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.